These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Jain R; Poisson L; Narang J; Gutman D; Scarpace L; Hwang SN; Holder C; Wintermark M; Colen RR; Kirby J; Freymann J; Brat DJ; Jaffe C; Mikkelsen T Radiology; 2013 Apr; 267(1):212-20. PubMed ID: 23238158 [TBL] [Abstract][Full Text] [Related]
4. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Jain R; Poisson LM; Gutman D; Scarpace L; Hwang SN; Holder CA; Wintermark M; Rao A; Colen RR; Kirby J; Freymann J; Jaffe CC; Mikkelsen T; Flanders A Radiology; 2014 Aug; 272(2):484-93. PubMed ID: 24646147 [TBL] [Abstract][Full Text] [Related]
5. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Colen RR; Wang J; Singh SK; Gutman DA; Zinn PO Radiology; 2015 Apr; 275(1):215-27. PubMed ID: 25490189 [TBL] [Abstract][Full Text] [Related]
6. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066 [TBL] [Abstract][Full Text] [Related]
7. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370 [TBL] [Abstract][Full Text] [Related]
8. Computer-extracted MR imaging features are associated with survival in glioblastoma patients. Mazurowski MA; Zhang J; Peters KB; Hobbs H J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma. Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347 [TBL] [Abstract][Full Text] [Related]
10. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance. Qian X; Tan H; Liu X; Zhao W; Chan MD; Kim P; Zhou X Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927654 [TBL] [Abstract][Full Text] [Related]
11. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M; J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477 [TBL] [Abstract][Full Text] [Related]
12. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. Czarnek N; Clark K; Peters KB; Mazurowski MA J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320 [TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of CSF and peri-tumoral edema volumes in glioblastoma. Mummareddy N; Salwi SR; Ganesh Kumar N; Zhao Z; Ye F; Le CH; Mobley BC; Thompson RC; Chambless LB; Mistry AM J Clin Neurosci; 2021 Feb; 84():1-7. PubMed ID: 33485591 [TBL] [Abstract][Full Text] [Related]
14. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Barajas RF; Hodgson JG; Chang JS; Vandenberg SR; Yeh RF; Parsa AT; McDermott MW; Berger MS; Dillon WP; Cha S Radiology; 2010 Feb; 254(2):564-76. PubMed ID: 20093527 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of TCTN1 in human glioblastoma. Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031 [TBL] [Abstract][Full Text] [Related]
16. Somatic mutations associated with MRI-derived volumetric features in glioblastoma. Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765 [TBL] [Abstract][Full Text] [Related]
17. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma. Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363 [TBL] [Abstract][Full Text] [Related]
18. Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma. Lee J; Jain R; Khalil K; Griffith B; Bosca R; Rao G; Rao A AJNR Am J Neuroradiol; 2016 Jan; 37(1):37-43. PubMed ID: 26471746 [TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]